Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Apr 15, 2026; 18(4): 115146
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.115146
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.115146
Table 2 Comparison of concordance of different groups
| Group | Consistent | Inconsistent | Concordance rate (%) |
| Category of disease severity | |||
| New cases | 105 | 5 | 95.5 |
| Previous case | 21 | 7 | 75.0 |
| Recurrent cases | 15 | 3 | 83.3 |
| Tumor, node, metastasis classification | |||
| Stage 0 | 1 | 0 | 100 |
| Stage I | 24 | 0 | 100 |
| Stage II | 21 | 0 | 100 |
| Stage III | 44 | 5 | 89.8 |
| Stage IV | 51 | 10 | 83.6 |
| Treatment | |||
| Surgery | 80 | 2 | 97.6 |
| Neoadjuvant chemotherapy | 7 | 0 | 100 |
| Adjuvant therapy | 8 | 3 | 72.7 |
| Palliative systemic therapy | 35 | 10 | 77.8 |
| Supportive treatment | 11 | 0 | 100 |
| Total | 141 | 15 | 90.4 |
- Citation: Chen TL, Yu XQ. Value of gastric cancer clinical decision support system in a single-center clinical application. World J Gastrointest Oncol 2026; 18(4): 115146
- URL: https://www.wjgnet.com/1948-5204/full/v18/i4/115146.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i4.115146